Ildong Pharmaceutical will be inevitable to have a voting challenge against Green Cross on the general meeting of shareholders

Triggered by the shareholder proposal of the 2^nd largest shareholder of Ildong Pharmaceutical, Green Cross, the M&A conflict between the two companies will lead to voting.

Ildong Pharmaceutical held a board meeting on the 26^th and decided to lay items to reappoint president Jung-chi Lee as its CEO and newly appoint CEO Chang-rokSeo of Human Asia as an outside director at the general meeting of...